NCT03911661View on ClinicalTrials.gov

Fearon Algorithm in Warfarin Patient Self-Management

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 20, 2018

Primary Completion Date

December 30, 2021

Study Completion Date

December 31, 2021

Conditions
Atrial FibrillationVenous ThrombosesHeart Valve Diseases
Interventions
OTHER

Fearon warfarin dosing algorithm

Blood test drawn by patient using a point of care INR monitor

OTHER

Usual care

Historical management of warfarin by patient's usual care providers

Trial Locations (1)

84112

University of Utah Thrombosis Center, Salt Lake City

All Listed Sponsors
collaborator

Roche Diagnostics GmbH

INDUSTRY

lead

University of Utah

OTHER

NCT03911661 - Fearon Algorithm in Warfarin Patient Self-Management | Biotech Hunter | Biotech Hunter